Format

Send to

Choose Destination
Am J Obstet Gynecol. 2009 Jun;200(6):610-2. doi: 10.1016/j.ajog.2009.04.004.

Magnesium sulfate for the prevention of cerebral palsy.

Author information

1
Center for Women's Reproductive Health, University of Alabama at Birmingham, Birmingham, AL 35249, USA. drouse@uab.edu

Abstract

Three large, randomized placebo-controlled trials of antenatal magnesium sulfate (MgSO(4)) for fetal neuroprotection have recently been conducted and reported. The results of these trials provide strong support for the utilization of MgSO(4) to lower the risk of cerebral palsy among the survivors of early preterm birth. In the United States, the use of MgSO(4) for fetal neuroprotection has the potential to prevent 1000 cases of handicapping cerebral palsy annually.

PMID:
19482114
DOI:
10.1016/j.ajog.2009.04.004
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center